| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A case of congenital prothrombin deficiency with two concurrent mutations in the prothrombin gene
|
Mansory, Eman M.
|
|
|
5 |
4 |
p.
|
artikel
|
| 2 |
Agreement of aptamer proteomics with standard methods for measuring venous thrombosis biomarkers
|
Faquih, Tariq
|
|
|
5 |
4 |
p.
|
artikel
|
| 3 |
A meta‐analysis of andexanet alfa and prothrombin complex concentrate in the treatment of factor Xa inhibitor–related major bleeding
|
Jaspers, Tessa
|
|
|
5 |
4 |
p.
|
artikel
|
| 4 |
Anti–factor Xa activity assays of direct‐acting oral anticoagulants during clinical care: An observational study
|
Sukumar, Smrithi
|
|
|
5 |
4 |
p.
|
artikel
|
| 5 |
Antithrombotics and new interventions for venous thromboembolism: Exploring possibilities beyond factor IIa and factor Xa inhibition
|
Mavromanoli, Anna C.
|
|
|
5 |
4 |
p.
|
artikel
|
| 6 |
Aspirin at 120: Retiring, recombining, or repurposing?
|
Patrono, Carlo
|
|
|
5 |
4 |
p.
|
artikel
|
| 7 |
Bias in animal studies of estrogen effects on cardiovascular disease: A systematic review and meta‐analysis
|
Friis Berntsen, Christopher
|
|
|
5 |
4 |
p.
|
artikel
|
| 8 |
Comparison is not reason: Pitfalls in reporting thrombin generation results in anticoagulated patients
|
Douxfils, Jonathan
|
|
|
5 |
4 |
p.
|
artikel
|
| 9 |
Comparison of novel thrombin generation methods with established techniques is mandatory
|
Helin, Tuukka
|
|
|
5 |
4 |
p.
|
artikel
|
| 10 |
Comparison of the coagulopathies associated with COVID‐19 and sepsis
|
Campbell, Robert A.
|
|
|
5 |
4 |
p.
|
artikel
|
| 11 |
Considerations for use of direct oral anticoagulants in arterial disease
|
Siegal, Deborah M.
|
|
|
5 |
4 |
p.
|
artikel
|
| 12 |
Deep learning detects and visualizes bleeding events in electronic health records
|
Pedersen, Jannik S.
|
|
|
5 |
4 |
p.
|
artikel
|
| 13 |
Delayed anticoagulation in venous thromboembolism: Reasons and associated outcomes
|
Brunton, Nichole E.
|
|
|
5 |
4 |
p.
|
artikel
|
| 14 |
Disruptive technology and hemophilia care: The multiple impacts of emicizumab
|
Hermans, Cedric
|
|
|
5 |
4 |
p.
|
artikel
|
| 15 |
Does publication bias explain the divergent findings on menopausal hormone therapy and cardioprotection in the literature?
|
El Khoudary, Samar R.
|
|
|
5 |
4 |
p.
|
artikel
|
| 16 |
Elevated von Willebrand factor levels during heavy menstrual bleeding episodes limit the diagnostic utility for von Willebrand disease
|
Brown, Megan C.
|
|
|
5 |
4 |
p.
|
artikel
|
| 17 |
Evaluating hemostatic thresholds for neuraxial anesthesia in adults with hemorrhagic disorders and tendencies: A scoping review
|
Peterson, Wynn
|
|
|
5 |
4 |
p.
|
artikel
|
| 18 |
Evaluation of point‐of‐care International Normalized Ratio in sickle cell disease
|
Rahman, Syeda
|
|
|
5 |
4 |
p.
|
artikel
|
| 19 |
Fibrinolysis and bleeding of unknown cause
|
Mehic, Dino
|
|
|
5 |
4 |
p.
|
artikel
|
| 20 |
GPIbα is the driving force of hepatic thrombopoietin generation
|
Karakas, Danielle
|
|
|
5 |
4 |
p.
|
artikel
|
| 21 |
Impact of oral anticoagulant choice for the secondary prevention of venous thromboembolism on the risk of inpatient bleeding
|
MacLehose, Richard F.
|
|
|
5 |
4 |
p.
|
artikel
|
| 22 |
Improved efficacy/safety profile of factor XIa inhibitor BMS‐724296 versus factor Xa inhibitor apixaban and thrombin inhibitor dabigatran in cynomolgus monkeys
|
Wong, Pancras C.
|
|
|
5 |
4 |
p.
|
artikel
|
| 23 |
Issue Information
|
|
|
|
5 |
4 |
p.
|
artikel
|
| 24 |
Management of therapeutic unfractionated heparin in COVID‐19 patients: A retrospective cohort study
|
Weeks, Lachelle D.
|
|
|
5 |
4 |
p.
|
artikel
|
| 25 |
Measuring the impact of hemophilia on families: Development of the Hemophilia Family Impact Tool (H‐FIT)
|
Dover, Saunya
|
|
|
5 |
4 |
p.
|
artikel
|
| 26 |
Micronized purified flavonoid fraction for the treatment of chronic venous insufficiency, with a focus on postthrombotic syndrome: A narrative review
|
Li, Ke Xuan
|
|
|
5 |
4 |
p.
|
artikel
|
| 27 |
Novel mutation in coagulation factor VII (Carmel mutation): Identification and characterization
|
Cassel, Aliza
|
|
|
5 |
4 |
p.
|
artikel
|
| 28 |
Patient‐relevant health outcomes for hemophilia care: Development of an international standard outcomes set
|
van Balen, Erna C.
|
|
|
5 |
4 |
p.
|
artikel
|
| 29 |
Reliability of patient‐reported outcome measures: Hemorrhage, anticoagulant, antiplatelet medication use
|
Selvanayagam, Nicholyn
|
|
|
5 |
4 |
p.
|
artikel
|
| 30 |
Reproductive issues in women on direct oral anticoagulants
|
Beyer‐Westendorf, Jan
|
|
|
5 |
4 |
p.
|
artikel
|
| 31 |
The contact activation system and vascular factors as alternative targets for Alzheimer's disease therapy
|
Singh, Pradeep K.
|
|
|
5 |
4 |
p.
|
artikel
|
| 32 |
Thromboprophylaxis with rivaroxaban in patients with malignancy and central venous lines (TRIM‐Line): A two‐center open‐label pilot randomized controlled trial
|
Ikesaka, Rick
|
|
|
5 |
4 |
p.
|
artikel
|
Tijdschrift beschrijving